NAD+ (Nicotinamide Adenine Dinucleotide)

Essential Cellular Coenzyme & Anti-Aging Therapy

Weight: 663.43 Da
Half-life: 1-4 hours (intracellular)
6 studies
2024 latest
3 recent
Extensively Studied
Dose IV: 250-1000mg; IM/SubQ: 100-500mg; Intranasal: 25-50mg; Oral precursors: 100-500mg NMN/NR
Frequency IV: 1-2x weekly; IM/SubQ: 2-3x weekly; Intranasal: 1-2x daily; Oral: daily
Cycle 4-12 weeks; IV therapy requires medical supervision
Storage Refrigerate at 2-8°C; protect from light
Accumulation Plotter

Community Research

Join others researching NAD+ — share findings, ask questions, and learn from real experiences

View Results Aggregated community findings
Discussion Questions & experiences
Submit Your Findings Contribute your research data

NAD+ is a crucial coenzyme found in every cell, involved in energy generation and cellular maintenance that naturally declines with age. Supplementation may support cellular health, boost energy, enhance cognitive function, and promote longevity through multiple delivery methods.

Mechanism of Action

Direct delivery to bloodstream ensures maximum cellular availability for energy production via ATP synthesis, DNA repair through PARP activation, and sirtuin-mediated longevity pathways. Supports mitochondrial function and metabolic homeostasis.

01 Restores mitochondrial function and ATP synthesis
02 Enhances glucose and fat metabolism
03 Improves oxygen utilization and endurance
04 Activates DNA repair mechanisms
05 Supports longevity pathways via sirtuins
06 Improves mental clarity and focus

Molecular Data

Molecular Weight
663.43 Da
Type
Coenzyme
Amino Acid Sequence
C21H27N7O14P2

Complex or non-standard sequence format

Peak 0.0 mcg
Trough 0.0 mcg
SS Peak 0.0 mcg
SS Trough 0.0 mcg

Research Indications

Energy & Metabolism
Cellular Energy Production most effective

Restores NAD+ levels for optimal ATP synthesis

Metabolic Optimization most effective

Enhances glucose and fat metabolism

Exercise Performance effective

Improves oxygen utilization and endurance

Anti-Aging
DNA Repair effective

Activates PARP enzymes for genomic stability

Sirtuin Activation effective

Supports longevity pathways

Cellular Senescence Reduction moderate

May help clear senescent cells

Neurological
Cognitive Enhancement moderate

Improves mental clarity and focus

Neuroprotection moderate

Supports neuronal health and function

Dosing Protocols

Highest bioavailability (100%) via IV, IM, or subcutaneous injection.

GoalDoseFrequencyRoute
IV Infusion250-1000mg1-2x weeklyIntravenous
IM/SubQ100-500mg2-3x weeklyIntramuscular or Subcutaneous

Interactions

++
BPC-157
Enhanced cellular repair and energy production
synergistic
++
TB-500
Complementary tissue regeneration effects
synergistic
+
Tirzepatide
Supports metabolic pathways enhanced by GLP-1 agonists
compatible
++
Ipamorelin
Growth hormone pathways benefit from improved energy metabolism
synergistic
+
CJC-1295
Enhanced recovery and anti-aging effects
compatible
!
Alcohol
Alcohol significantly reduces NAD+ levels and effectiveness
avoid

What to Expect

Week 1-2
Initial energy improvements and mental clarity
Week 3-4
Enhanced physical performance and recovery
Week 5-8
Sustained energy levels and improved sleep quality
Week 9-12
Optimized metabolic function and cognitive benefits

Side Effects & Safety

Common Side Effects

  • Mild flushing during IV infusion
  • Temporary nausea

Stop Signs - Discontinue if:

  • Severe injection site reactions or infection signs
  • Persistent nausea or gastrointestinal distress
  • Unusual fatigue or weakness
  • Allergic reactions (rash, swelling, breathing difficulty)

Contraindications

  • IV administration requires medical supervision
  • Avoid alcohol during treatment
  • Maintain consistent dosing schedule

Quality Checklist

Good Signs

  • Clear, colorless solution (injectable)
  • Proper refrigeration at 2-8°C
  • Sterile injection technique
  • Third-party tested for purity

Warning Signs

  • Use reconstituted solution within 28 days

Bad Signs

  • Cloudy or discolored solution indicates contamination
  • Room temperature storage degrades NAD+ rapidly

References

  • NAD+ and Sirtuins in Aging and Disease
    Imai, S., Guarente, L.
    Trends in Cell Biology (2014)

    Seminal review establishing that NAD+ decline is central to aging, driving defects in sirtuin-mediated nuclear and mitochondrial functions and resulting in age-associated pathologies.

  • Chronic Nicotinamide Riboside Supplementation Is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults
    Martens, C.R., et al.
    Nature Communications (2018)

    Randomized crossover trial showing NR (1000 mg/day for 6 weeks) is well tolerated and effectively elevates NAD+ in healthy middle-aged and older adults, with preliminary evidence for reduced blood pressure and arterial stiffness.

  • Nicotinamide Mononucleotide Increases Muscle Insulin Sensitivity in Prediabetic Women
    Yoshino, M., et al.
    Science (2021)

    First human clinical trial showing NMN (250 mg/day for 10 weeks) increases skeletal muscle insulin signaling and sensitivity in overweight/obese postmenopausal women with prediabetes.

  • NAD+ Metabolism and Its Roles in Cellular Processes During Ageing
    Covarrubias, A.J., et al.
    Nature Reviews Molecular Cell Biology (2021)

    Comprehensive review of NAD+ metabolism during aging, detailing how senescent cells drive NAD+ decline via CD38+ macrophage activation and outlining therapeutic restoration strategies.

  • Efficacy of Oral NMN Supplementation on Glucose and Lipid Metabolism: A Systematic Review with Meta-Analysis of RCTs
    Zhong, O., et al.
    Journal of Translational Medicine (2024)

    Meta-analysis of 8 RCTs (342 adults) found NMN significantly elevates blood NAD+ levels, but short-term supplementation (250-2000 mg/d) did not show significant improvements in glucose control or lipid profile in the general population.

  • A Randomized Placebo-Controlled Trial of Nicotinamide Riboside in Older Adults with Mild Cognitive Impairment
    Orr, M.E., et al.
    GeroScience (2024)

    NR was well tolerated and significantly increased blood NAD+ concentrations in older adults with MCI. Global methylation analyses indicated modest NR-associated reduction in epigenetic age by PhenoAge and GrimAge clocks.

Related Peptides

BPC-157 synergistic

Enhanced cellular repair and energy production

TB-500 synergistic

Complementary tissue regeneration effects

Tirzepatide compatible

Supports metabolic pathways enhanced by GLP-1 agonists

Ipamorelin synergistic

Growth hormone pathways benefit from improved energy metabolism

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.